A research team led by a University of Cambridge scientist has found that in the brain, cholesterol acts as a catalyst which triggers the formation of the toxic clusters of the amyloid-beta protein, a central player in the development of Alzheimer’s disease. It is unclear, however, if the results — published in the journal Nature Chemistry — have any implications for dietary cholesterol, as cholesterol does not cross the blood-brain...